论文部分内容阅读
目的观察氯沙坦和前列腺素E1联合治疗糖尿病肾病(DN)的疗效。方法临床将糖尿病肾病60例患者随机分成3组,分别为氯沙坦组,前列腺素E1组及联合用药组,疗程均为4周,观察用药前后的尿白蛋白排泄率(UAER)。结果各组UAER均有明显降低(P<0.05),联合用药组与单独用药组比较,差异有显著性。结论氯沙坦联合前列腺素E1治疗早期糖尿病肾病较单独应用更有效,从而预防和延缓2型糖尿病肾病的病程。
Objective To observe the effect of losartan and prostaglandin E1 in the treatment of diabetic nephropathy (DN). Methods Sixty patients with diabetic nephropathy were randomly divided into three groups: losartan, prostaglandin E1 and combination therapy. The course of treatment was 4 weeks. Urinary albumin excretion rate (UAER) was observed before and after treatment. Results The UAER in each group was significantly lower (P <0.05). There was significant difference between the combination group and the drug alone group. Conclusion Losartan combined with prostaglandin E1 in the treatment of early diabetic nephropathy is more effective than single application, thus preventing and delaying the course of type 2 diabetic nephropathy.